drugset / Trial / NCT00821392
Phase III Trial of Febuxostat in Korea Gout Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study was designed to evalute the efficacy and safety of Febuxostat after oral administration to patientd with gout in Korea
Timeline
- Start
- 2006-08
- Primary completion
- 2007-09
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Febuxostat | Small molecule | 40 mg | Oral |
| Comparator | Febuxostat | Small molecule | 80 mg | Oral |
| Comparator | Febuxostat | Small molecule | 120 mg | Oral |